Benitec Biopharma (BNTC) Amortizatization of Intangibles (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $330000.0 as the latest value for Q2 2025.

  • Quarterly Amortizatization of Intangibles rose 407.69% to $330000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $330000.0 through Jun 2025, up 28.91% year-over-year, with the annual reading at $330000.0 for FY2025, 28.91% up from the prior year.
  • Amortizatization of Intangibles hit $330000.0 in Q2 2025 for Benitec Biopharma, up from -$66000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $330000.0 in Q2 2025 to a low of -$66000.0 in Q4 2024.
  • Historically, Amortizatization of Intangibles has averaged $67882.4 across 5 years, with a median of $61000.0 in 2022.
  • Biggest five-year swings in Amortizatization of Intangibles: plummeted 204.76% in 2024 and later surged 407.69% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $58000.0 in 2021, then rose by 5.17% to $61000.0 in 2022, then increased by 3.28% to $63000.0 in 2023, then tumbled by 204.76% to -$66000.0 in 2024, then surged by 600.0% to $330000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for BNTC at $330000.0 in Q2 2025, -$66000.0 in Q4 2024, and $66000.0 in Q3 2024.